Scotland to get new facility for regenerative medicine
A world-leading center for excellence in regenerative medicine and stem cells is to be built in Edinburgh, Scotland, ministers have confirmed. Funding support of L24.0 million ($46.4 million) from the Scottish Executive will allow the L59.0 million Scottish Center for Regenerative Medicine (SCRM) to be developed by the University of Edinburgh in close collaboration with Scottish Enterprise.
The SCRM, which will be part of the new Center for Biomedical Research at Edinburgh's Little France, will be unique in Europe and is thought to be equalled only by Kobe in Japan on a global level, it was noted. In providing state-of-the-art research facilities, manufacturing capacity and commercialization facilities, the SCRM will have three main elements: high-quality accommodation to support 220 academic researchers; a center for scale-up
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze